Data, disease and diplomacy: GISAID's innovative contribution to global health

Elbe, Stefan, Buckland‐Merrett, Gemma·2017·Global Challenges
DOI 10.1002/gch2.1018

Cited by (1,006)

Items 101–200 of 1,006

  1. Highly Pathogenic Avian Influenza (HPAI) H5 Clade 2.3.4.4b Virus Infection in Birds and Mammals
    Giulia Graziosi, Caterina Lupini, Elena Catelli, Silvia Carnaccini · 2024 · Animals
  2. Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
    Boras, Britton, Jones, Rhys M., Anson, Brandon J., Arenson, Dan, Aschenbrenner, Lisa, Bakowski, Malina A., Beutler, Nathan, Binder, Joseph, Chen, Emily, Eng, Heather et al. · 2020
  3. Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
    Alief Moulana, Thomas Dupic, Angela M. Phillips, Jeffrey Chang, Serafina Nieves, Anne A. Roffler, Allison J. Greaney, Tyler N. Starr, Jesse D. Bloom, Michael M. Desai · 2022 · Nature Communications
  4. Transmission of SARS-CoV-2 from humans to animals and potential host adaptation
    Cedric C.S. Tan, Su Datt Lam, Damien Richard, Christopher J. Owen, Dorothea Berchtold, Christine Anne Orengo, Meera Surendran Nair, Suresh Varma Kuchipudi, Vivek Kapur, Lucy van Dorp et al. · 2022 · Nature Communications
  5. Ongoing mpox outbreak in Kamituga, South Kivu province, associated with monkeypox virus of a novel Clade I sub-lineage, Democratic Republic of the Congo, 2024
    Leandre Murhula Masirika, Jean Claude Udahemuka, Leonard Schuele, Pacifique Ndishimye, Saria Otani, Justin Bengehya Mbiribindi, Jean M. Marekani, Léandre Mutimbwa Mambo, Nadine Malyamungu-Bubala, Marjan Boter et al. · 2024 · Eurosurveillance
  6. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC
    Praveen Anand, Arjun Puranik, Murali Aravamudan, AJ Venkatakrishnan, Venky Soundararajan · 2020 · eLife
  7. Antibody-mediated neutralization of SARS-CoV-2
    Henning Gruell, Kanika Vanshylla, Timm Weber, Christopher O. Barnes, Christoph Kreer, Florian Klein · 2022 · Immunity
  8. Drivers of adaptive evolution during chronic SARS-CoV-2 infections
    Sheri Harari, Maayan Tahor, Natalie Rutsinsky, Suzy E. Meijer, Danielle Miller, Oryan Henig, Ora Halutz, Katia Levytskyi, Ronen Ben‐Ami, Amos Adler et al. · 2022 · Nature Medicine
  9. Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research
    Franziska Hufsky, Kevin Lamkiewicz, Alexandre Almeida, Abdel Aouacheria, Cecilia N. Arighi, Alex G. Bateman, Jan Baumbach, Niko Beerenwinkel, Christian Brandt, Marco Cacciabue et al. · 2020 · Briefings in Bioinformatics
  10. First and second COVID-19 waves in Brazil: A cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortality
    Felipe André Zeiser, Bruna Donida, Cristiano André da Costa, Gabriel de Oliveira Ramos, Juliana Nichterwitz Scherer, Nêmora Tregnago Barcellos, Ana Paula Alegretti, Maria Letícia Rodrigues Ikeda, Ana Paula Wernz C. Müller, Henrique C. Bohn et al. · 2021 · The Lancet Regional Health - Americas
  11. Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay
    James P. Broughton, Xianding Deng, Guixia Yu, Clare L. Fasching, Jasmeet Singh, Jessica A. Streithorst, Andrea C. Granados, Alicia Sotomayor-González, Kelsey C. Zorn, Allan Gopez et al. · 2020 · medRxiv
  12. Surveillance of European Domestic Pig Populations Identifies an Emerging Reservoir of Potentially Zoonotic Swine Influenza A Viruses
    Dinah Henritzi, Philipp P. Petric, Nicola S. Lewis, Annika Graaf, Alberto Pessia, Elke Starick, Angele Breithaupt, Günter Strebelow, Christine Luttermann, Larissa Mareike Kristin Parker et al. · 2020 · Cell Host & Microbe
  13. Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19
    M. Yu. Shkurnikov, Stepan A. Nersisyan, Tatjana Jankevic, Alexei Vladimirovich Galatenko, Ivan G. Gordeev, Valery I. Vechorko, Alexander Tonevitsky · 2021 · Frontiers in Immunology
  14. SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376
    Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, Chengjin Ye, Matteo Pavan, Davide Bassani, André Volland, Claudia Ascher, Alexander K. H. Weiss, David Bante et al. · 2022 · Science Translational Medicine
  15. Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020
    Pilailuk Akkapaiboon Okada, Rome Buathong, Siripaporn Phuygun, Thanutsapa Thanadachakul, Sittiporn Parnmen, Warawan Wongboot, Sunthareeya Waicharoen, Supaporn Wacharapluesadee, Sumonmal Uttayamakul, Apichart Vachiraphan et al. · 2020 · Eurosurveillance
  16. Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic
    Javier Escalada-San Martín, Dimitra Klapsa, Thomas Wilton, Maria Cristina Fleischmann Alves Zambon, Emma M. Bentley, Erika Bujáki, Martin Fritzsche, Ryan Mate, Manasi Majumdar · 2020 · Viruses
  17. CRISPR Systems for COVID-19 Diagnosis
    Hossein Rahimi, Marziyeh Salehiabar, Murat Barsbay, Mohammadreza Ghaffarlou, Taras S. Kavetskyy, Ali Sharafi, Soodabeh Davaran, Subhash C. Chauhan, Hossein Danafar, Saeed Kaboli et al. · 2021 · ACS Sensors
  18. Virus classification for viral genomic fragments using PhaGCN2
    Jing‐Zhe Jiang, Wen-Guang Yuan, Jiayu Shang, Ying-Hui Shi, Liling Yang, Min Liu, Peng Zhu, Tao Jin, Yanni Sun, Lihong Yuan · 2022 · Briefings in Bioinformatics
  19. Isolation of clade 2.3.4.4b A(H5N8), a highly pathogenic avian influenza virus, from a worker during an outbreak on a poultry farm, Russia, December 2020
    Olga G. Pyankova, Ivan M. Susloparov, Anastasia A. Moiseeva, Natalia P. Kolosova, Онхонова Галина Сергеевна, Alexey V. Danilenko, Elena V. Vakalova, Gennady L Shendo, Natalia N Nekeshina, L. N. Noskova et al. · 2021 · Eurosurveillance
  20. COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses
    Zhiyuan Chen, Joseph L.-H. Tsui, Bernardo Gutiérrez, Simon Busch‐Moreno, Louis du Plessis, Xiaowei Deng, Jun Cai, Sumali Bajaj, Marc A. Suchard, Oliver G. Pybus et al. · 2024 · Science
  21. Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models
    Han-Yi Huang, Hsin-Yu Liao, Xiaorui Chen, Szu-Wen Wang, Cheng-Wei Cheng, Md. Shahed-Al-Mahmud, Yo-Min Liu, Arpita Mohapatra, Ting-Hua Chen, Jennifer M. Lo et al. · 2022 · Science Translational Medicine
  22. Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells
    Claudia R. Arbeitman, Gabriela Alejandra Auge, Matı́as Blaustein, Luis M. Bredeston, Enrique Corapi, Patricio O. Craig, Leandro A. Cossio, Liliana Daín, Cecilia D’Alessio, Fernanda Elias et al. · 2020 · Scientific Reports
  23. SARS-CoV-2 RBD <i>in vitro</i> evolution follows contagious mutation spread, yet generates an able infection inhibitor
    Zahradník, Jiří, Marciano, Shir, Shemesh, Maya, Zoler, Eyal, Chiaravalli, Jeanne, Meyer, Björn, Rudich, Yinon, Dym, Orly, Elad, Nadav, Schreiber, Gideon · 2021
  24. Digital CRISPR-based method for the rapid detection and absolute quantification of nucleic acids
    Xiaolin Wu, Joshua K. Tay, Chuan Keng Goh, Cheryl Siew Choo Chan, Yie Hou Lee, Stacy L. Springs, De Yun Wang, Kwok Seng Loh, Timothy K. Lu, Hanry Yu · 2021 · Biomaterials
  25. Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function
    Darren Patrick Martin, Spyros Lytras, Alexander G. Lucaci, Wolfgang Maier, Björn Andreas Grüning, Stephen D. Shank, Steven Weaver, Oscar A. MacLean, Richard J Orton, Philippe Lemey et al. · 2022 · Molecular Biology and Evolution
  26. Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis
    Chen, Xinhua, Chen, Zhiyuan, Azman, Andrew S, Sun, Ruijia, Lu, Wanying, Zheng, Nan, Zhou, Jiaxin, Wu, Qianhui, Deng, Xiaowei, Zhao, Zeyao et al. · 2022 · Clinical Infectious Diseases
  27. SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals
    Su Datt Lam, Nicola Bordin, Vaishali Waman, Harry M. Scholes, Paul Ashford, Neeladri Sen, Lucy van Dorp, Clemens Rauer, Natalie L. Dawson, Camilla Pang et al. · 2020 · Scientific Reports
  28. Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677
    Emma B. Hodcroft, Daryl Domman, Daniel J. Snyder, Kasopefoluwa Y. Oguntuyo, Maarten Van Diest, Kenneth H. Densmore, Kurt C. Schwalm, Jon Femling, Jennifer L. Carroll, Rona S. Scott et al. · 2021 · medRxiv
  29. The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR
    Shuhui Song, Lina Ma, Dong Zou, Dongmei Tian, Cuiping Li, Junwei Zhu, Meili Chen, Anke Wang, Yingke Ma, Mengwei Li et al. · 2020 · Genomics Proteomics & Bioinformatics
  30. Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis
    Evangelou, Konstantinos, Veroutis, Dimitris, Paschalaki, Koralia, Foukas, Periklis G., Lagopati, Nefeli, Dimitriou, Marios, Papaspyropoulos, Angelos, Konda, Bindu, Hazapis, Orsalia, Polyzou, Aikaterini et al. · 2022 · European Respiratory Journal
  31. CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes
    Dave Baker, Alp Aydin, Thanh Le-Viet, Gemma L. Kay, Steven J. Rudder, Leonardo de Oliveira Martins, Ana P. Tedim, Anastasia Kolyva, María Díaz, Nabil-Fareed Alikhan et al. · 2021 · Genome Medicine
  32. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest
    Albert Tian Chen, Kevin Altschuler, Shing H. Zhan, Yujia A. Chan, Benjamin E. Deverman · 2021 · eLife
  33. Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand
    Jemma L. Geoghegan, Xiaoyun Ren, Matthew Storey, James Hadfield, Lauren Jelley, Sarah Jefferies, Jill Sherwood, Shevaun Paine, Q. Sue Huang, Jordan Douglas et al. · 2020 · Nature Communications
  34. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
    Satoshi Ikegame, Mohammed Nure Alam Siddiquey, Chuan-Tien Hung, Griffin D. Haas, Luca Brambilla, Kasopefoluwa Y. Oguntuyo, Shreyas Kowdle, Hsin-Ping Chiu, Christian S. Stevens, Ariel Esteban Vilardo et al. · 2021 · Nature Communications
  35. Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories
    Yong Ge, Wenbin Zhang, Xilin Wu, Corrine Warren Ruktanonchai, Haiyan Liu, Jianghao Wang, Yongze Song, Mengxiao Liu, Wei Yan, Juan Yang et al. · 2022 · Nature Communications
  36. The Emergence of SARS-CoV-2 Variants of Concern Is Driven by Acceleration of the Substitution Rate
    John H Tay, Ashleigh F. Porter, Wytamma Wirth, Sebastián Duchêne · 2022 · Molecular Biology and Evolution
  37. A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)
    Alexander B. Ryzhikov, Marina P. Bogryantseva, S. V. Usova, Е. Д. Даниленко, Нечаева Елена Августовна, Oleg V. Pyankov, Olga G. Pyankova, Andrei S. Gudymo, С. А. Боднев, Онхонова Галина Сергеевна et al. · 2021 · Russian Journal of Infection and Immunity
  38. Estimating the impact of COVID-19 vaccine inequities: a modeling study
    Nicolò Gozzi, Matteo Chinazzi, Natalie E. Dean, Ira M. Longini, M. Elizabeth Halloran, Nicola Perra, Alessandro Vespignani · 2023 · Nature Communications
  39. The relationship between innovative human capital and interprovincial economic growth based on panel data model and spatial econometrics
    Yunfu Xu, Aiya Li · 2019 · Journal of Computational and Applied Mathematics
  40. Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants
    Natália Teruel, Olivier Mailhot, Rafaël Najmanovich · 2021 · PLoS Computational Biology
  41. Potential role of cellular miRNAs in coronavirus-host interplay
    Stepan A. Nersisyan, Narek Engibaryan, Aleksandra Gorbonos, Ksenia Kirdey, Alexey M. Makhonin, Alexander Tonevitsky · 2020 · PeerJ
  42. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco
    Gabriel Chamie, Carina Marquez, Emily D. Crawford, James Peng, Maya L Petersen, Daniel Schwab, Joshua Schwab, Jackie Martinez, Diane Jones, Douglas Black et al. · 2020 · Clinical Infectious Diseases
  43. Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion
    Veronique R. Nussenblatt, Allison E. Roder, Sanchita Basu Das, Emmie de Wit, Jung-Ho Youn, Stephanie Banakis, Alexandra A. Mushegian, Christopher Mederos, Wei Wang, Matthew C. Chung et al. · 2021 · The Journal of Infectious Diseases
  44. SARS coronavirus 2: from genome to infectome
    Meghana Rastogi, Neha Pandey, Astha Shukla, Sunit K. Singh · 2020 · Respiratory Research
  45. SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants
    Surabhi Srivastava, Sofia Banu, Priya Singh, Divya Tej Sowpati, Rakesh K. Mishra · 2021 · Journal of Biosciences
  46. Recombinant SARS-CoV-2 genomes circulated at low levels over the first year of the pandemic
    David VanInsberghe, Andrew Scott Neish, Anice C. Lowen, Katia Koelle · 2021 · Virus Evolution
  47. Genetic Surveillance of SARS-CoV-2 M pro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid
    Jonathan T. Lee, Qingyi Yang, Alexey V. Gribenko, Bradley Scott Perrin, Yuao Zhu, Rhonda D. Cardin, Paul Liberator, Annaliesa S. Anderson, Hao Li · 2022 · mBio
  48. Global landscape of SARS-CoV-2 mutations and conserved regions
    Mohammad Hadi Abbasian, Mohammadamin Mahmanzar, Karim Rahimian, Bahar Mahdavi, Samaneh Tokhanbigli, Bahman Moradi, Mahsa Mollapour Sisakht, Youping Deng · 2023 · Journal of Translational Medicine
  49. Host-directed editing of the SARS-CoV-2 genome
    Tobias Mourier, Mukhtar Sadykov, Michael J. Carr, Gabriel González, William W. Hall, Arnab Pain · 2020 · Biochemical and Biophysical Research Communications
  50. Covid-19 Infection in India: A Comparative Analysis of the Second Wave with the First Wave
    Arnab Sarkar, Alok Chakrabarti, Shanta Dutta · 2021 · Pathogens
  51. COVID-19 pandemic reveals the peril of ignoring metadata standards
    Lynn M. Schriml, Maria S. Chuvochina, Neil Davies, Emiley A. Eloe‐Fadrosh, Robert D. Finn, Philip Hugenholtz, Chris Hunter, Bonnie L. Hurwitz, Nikos C. Kyrpides, Folker Meyer et al. · 2020 · Scientific Data
  52. Phylogenetic and phylodynamic analyses of SARS-CoV-2
    Qing Hua Nie, Xingguang Li, Wei Chen, Dehui Liu, Yingying Chen, Haitao Li, Dongying Li, Mengmeng Tian, Wei Chang Colin Tan, Junjie Zai · 2020 · Virus Research
  53. Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease?
    Yue‐Hin Loke, Charles I. Berul, Ashraf S. Harahsheh · 2020 · Trends in Cardiovascular Medicine
  54. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
    A. Deshpande, Bethany D. Harris, L. Martínez-Sobrido, J. Kobie, M. Walter · 2021 · bioRxiv
  55. Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking
    Yu‐Chuan Chang, Yi‐An Tung, Ko-Han Lee, Ting-Fu Chen, Yu‐Chun Hsiao, Hung-Ching Chang, Tsung-Ting Hsieh, Chan-Hung Su, Su-Shia Wang, Jheng-Ying Yu et al. · 2020 · Preprints.org
  56. Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
    Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Bruce R. Zetter, Michael S. Rogers, Bradley L. Pentelute, Jonathan M. Carlson, Mark S. Hixon, Diane Joseph‐McCarthy et al. · 2021 · PLoS ONE
  57. Multiplex SARS-CoV-2 Genotyping Reverse Transcriptase PCR for Population-Level Variant Screening and Epidemiologic Surveillance
    Hannah Wang, Jacob A. Miller, Michelle Verghese, Mamdouh Sibai, Daniel Solis, Kenji O. Mfuh, Becky Jiang, Naomi Iwai, Marilyn Mar, ChunHong Huang et al. · 2021 · Journal of Clinical Microbiology
  58. Phase separation by the SARS-CoV-2 nucleocapsid protein: Consensus and open questions
    Sean M. Cascarina, Eric D. Ross · 2022 · Journal of Biological Chemistry
  59. Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants
    James W. Saville, Dhiraj Mannar, Xing Quan Zhu, Shanti Swaroop Srivastava, Alison Berezuk, Jean‐Philippe Demers, Steven Zhou, Katharine S. Tuttle, Inna Sekirov, Andrew Kim et al. · 2022 · Nature Communications
  60. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
    Pancer, Katarzyna, Milewska, Aleksandra, Owczarek, Katarzyna, Dabrowska, Agnieszka, Kowalski, Michał, Łabaj, Paweł P., Branicki, Wojciech, Sanak, Marek, Pyrc, Krzysztof · 2020 · PLOS Pathogens
  61. Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag
    Pradhan, Prashant, Pandey, Ashutosh Kumar, Mishra, Akhilesh, Gupta, Parul, Tripathi, Praveen Kumar, Menon, Manoj Balakrishnan, Gomes, James, Vivekanandan, Perumal, Kundu, Bishwajit · 2020 · Retracted
  62. Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV‑2 Mpro
    Olivier Sheik Amamuddy, Gennady M. Verkhivker, Özlem Taştan Bishop · 2020 · Journal of Chemical Information and Modeling
  63. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
    Johannes F. Scheid, Christopher O. Barnes, Basak Eraslan, Andrew Hudak, Jennifer R. Keeffe, Lisa A. Cosimi, Eric Brown, Frauke Muecksch, Yiska Weisblum, Shuting Zhang et al. · 2021 · Cell
  64. Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing
    Géraldine Rios, Caroline Lacoux, Vianney Leclercq, Anna Diamant, Kévin Lebrigand, Adèle Lazuka, E. Soyeux, Sébastien Lacroix, Julien Fassy, Aurélie Couesnon et al. · 2021 · The Lancet Regional Health - Europe
  65. Mutation-induced Changes in the Receptor-binding Interface of the SARS-CoV-2 Delta Variant B.1.617.2 and Implications for Immune Evasion
    Prabin Baral, Nisha Bhattarai, Md Lokman Hossen, Vitalii Stebliankin, Bernard S. Gerstman, Giri Narasimhan, Prem P. Chapagain · 2021 · Biochemical and Biophysical Research Communications
  66. Molecular evolutionary characteristics of SARS‐CoV‐2 emerging in the United States
    Shihang Wang, Xuanyu Xu, Cai Wei, Sicong Li, Jingying Zhao, Yin Zheng, Xiaoyu Liu, Xiaomin Zeng, Wenliang Yuan, Sihua Peng · 2021 · Journal of Medical Virology
  67. The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape
    Martin, Darren P, Weaver, Steven, Tegally, Houryiah, San, Emmanuel James, Shank, Stephen D, Wilkinson, Eduan, Lucaci, Alexander G, Giandhari, Jennifer, Naidoo, Sureshnee, Pillay, Yeshnee et al. · 2021
  68. Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site
    Umesh Kalathiya, Monikaben Padariya, Marcos Yébenes Mayordomo, Malgorzata M. Lisowska, Judith Nicholson, A. Jonathan Singh, Maciej Bagiński, Robin Fåhræus, Neil O. Carragher, Kathryn L. Ball et al. · 2020 · Journal of Clinical Medicine
  69. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment
    Liang Chen, Michael C. Zody, Clara Di Germanio, Rachel Martinelli, José R. Mediavilla, Marcus H. Cunningham, Kaelea Composto, Kar Fai Chow, Milena Kordalewska, André Corvelo et al. · 2021 · mSphere
  70. Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York
    Anthony P. West, Joel O. Wertheim, Jade C. Wang, Tetyana I. Vasylyeva, Jennifer L. Havens, Moinuddin A. Chowdhury, Edimarlyn Gonzalez, Courtney E. Fang, Steve S. Di Lonardo, Scott Hughes et al. · 2021 · Nature Communications
  71. Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus
    Syed Faraz Ahmed, Muhammad Saqib Sohail, Ahmed Abdul Quadeer, Matthew R. McKay · 2022 · Viruses
  72. Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic — China, October 2016–February 2017
    Angela Danielle Iuliano, Yunho Jang, Joyce E. Jones, Charles Todd Davis, David E. Wentworth, Timothy M. Uyeki, Katherine M. Roguski, Mark G. Thompson, Larisa V. Gubareva, Alicia M. Fry et al. · 2017 · MMWR Morbidity and Mortality Weekly Report
  73. Emerging Microbes & Infections
    Kwok‐Yung Yuen · 2016
  74. Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking
    Yu‐Chuan Chang, Yi‐An Tung, Ko-Han Lee, Ting-Fu Chen, Yu‐Chun Hsiao, Hung-Ching Chang, Tsung-Ting Hsieh, Chan-Hung Su, Su-Shia Wang, Jheng-Ying Yu et al. · 2020 · Preprints.org
  75. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2
    Zhiqiang Zheng, Vanessa Monteil, Sebastian Maurer‐Stroh, Chow Wenn Yew, Carol Leong, Nur Khairiah Mohd-Ismail, Suganya Cheyyatraivendran Arularasu, Vincent T. K. Chow, Raymond Tzer Pin Lin, Alì Mirazimi et al. · 2020 · Eurosurveillance
  76. Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes
    Juan Rodriguez-Rivas, Giancarlo Croce, Maureen Muscat, Martin Weigt · 2022 · Proceedings of the National Academy of Sciences
  77. Lineage abundance estimation for SARS-CoV-2 in wastewater using transcriptome quantification techniques
    Jasmijn A. Baaijens, Alessandro Zulli, Isabel M. Ott, Ioanna Nika, Mart J. van der Lugt, Mary E. Petrone, Tara Alpert, Joseph R. Fauver, Chaney C. Kalinich, Chantal B. F. Vogels et al. · 2022 · Genome biology
  78. Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
    Antonio E. Muruato, Michelle N. Vu, Bryan A. Johnson, Meredith E. Davis-Gardner, Abigail Vanderheiden, Kumari G. Lokugamage, Craig Schindewolf, Patricia A. Crocquet-Valdes, Rose M. Langsjoen, Jessica A. Plante et al. · 2021 · PLoS Biology
  79. Deep-learning-enabled protein–protein interaction analysis for prediction of SARS-CoV-2 infectivity and variant evolution
    Guangyu Wang, Xiaohong Liu, Kai Wang, Yuanxu Gao, Gen Li, Daniel Tomas Baptista‐Hon, Xiaohong Helena Yang, Kanmin Xue, Wa Hou Tai, Zeyu Jiang et al. · 2023 · Nature Medicine
  80. Identification of a Polymorphism in the N Gene of SARS-CoV-2 That Adversely Impacts Detection by Reverse Transcription-PCR
    Manu Vanaerschot, Sabrina A Mann, James T. Webber, Jack Kamm, Sidney M. Bell, John Bell, Si Noon Hong, Minh Phuong Nguyen, Lienna Y. Chan, Karan D. Bhatt et al. · 2020 · Journal of Clinical Microbiology
  81. Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic
    Andrew Santiago‐Frangos, Laina N. Hall, Anna Nemudraia, Artem A. Nemudryi, Pushya Krishna, Tanner Wiegand, Royce A. Wilkinson, Deann Teresa Snyder, Jodi F. Hedges, Calvin Cicha et al. · 2021 · Cell Reports Medicine
  82. Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assay
    Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata · 2020 · Journal of Virological Methods
  83. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain
    Francisco Díez‐Fuertes, María Iglesias‐Caballero, Javier García‐Pérez, Sara Monzón, Pilar Jiménez, Sarai Varona, Isabel Cuesta, Ángel Zaballos, Mercedes Jiménez, Laura Checa et al. · 2020 · Journal of Virology
  84. Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2
    Chen Chen, Veda Sheersh Boorla, Deepro Banerjee, Ratul Chowdhury, Victoria S. Cavener, Ruth Helmus Nissly, Abhinay Gontu, Nina R. Boyle, Kurt J. Vandegrift, Meera Surendran Nair et al. · 2021 · Proceedings of the National Academy of Sciences
  85. Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study
    Miguel I. Paredes, Stephanie M. Lunn, Michael Famulare, Lauren A. Frisbie, Ian S Painter, Roy Burstein, Pavitra Roychoudhury, Hong Jian Xie, Shah A. Mohamed Bakhash, Ricardo Perez et al. · 2022 · Clinical Infectious Diseases
  86. SARS-CoV-2 genomic surveillance in wastewater as a model for monitoring evolution of endemic viruses
    Mukhlid Yousif, Said Rachida, Setshaba Taukobong, Nkosenhle Ndlovu, Chinwe Juliana Iwu, Wayne Howard, Shelina Moonsamy, Nompilo Mhlambi, Sipho Gwala, Joshua I. Levy et al. · 2023 · Nature Communications
  87. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
    Ann-Kathrin Reuschl, Lucy G. Thorne, M. Whelan, Roberta Ragazzini, Wilhelm Furnon, Vanessa M. Cowton, G. De Lorenzo, Dejan Mesner, Jane Turner, Giulia Dowgier et al. · 2023 · bioRxiv
  88. Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
    Katherine Nabel Smith, Sarah A. Clark, Sundaresh Shankar, Junhua Pan, Lars E. Clark, Pan Yang, Adrian Coscia, Lindsay G. A. McKay, Haley Varnum, Vesna Brusic et al. · 2022 · Science
  89. Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa)
    Nick Eichler, Craig Thornley, Tara Swadi, Tom Devine, Caroline McElnay, Jillian Sherwood, Cheryl R. Brunton, Felicity Williamson, Josh Freeman, Sarah Jane Berger et al. · 2021 · Emerging infectious diseases
  90. Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage
    Cathrine Scheepers, Josie Everatt, Daniel Gyamfi Amoako, Houriiyah Tegally, Constantinos Kurt Wibmer, Anele Mnguni, Arshad Ismail, Boitshoko Mahlangu, Bronwen E. Lambson, Simone I. Richardson et al. · 2022 · Nature Communications
  91. The ocean genome and future prospects for conservation and equity
    Robert Blasiak, Rachel Wynberg, Kirsten Grorud‐Colvert, Siva Thambisetty, Narcisa Maria Bandarra, Adelino V. M. Canário, Jessica Marie da Silva, Carlos Manuel Duarte, Marcel Jaspars, Alex David Rogers et al. · 2020 · Nature Sustainability
  92. SARS-CoV-2 Delta Variant among Asiatic Lions, India
    Anamika Mishra, Naveen Kumar, Sandeep Bhatia, Ashutosh Aasdev, Sridhar Kanniappan, Abelraj Thaya Sekhar, Aparna Gopinadhan, Ramu Silambarasan, Chirukandoth Sreekumar, Chandan Kumar Dubey et al. · 2021 · Emerging infectious diseases
  93. SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load
    Tobias Mourier, Muhammad Shuaib, Sharif M. Hala, Sara Mfarrej, Fadwa S. Alofi, Raeece Naeem, Afrah Alsomali, David Jorgensen, Amit Kumar Subudhi, Fathia Ben-Rached et al. · 2022 · Nature Communications
  94. SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
    Henning Gruell, Kanika Vanshylla, Michael Korenkov, Pinkus Tober‐Lau, Matthias Zehner, Friederike Münn, Hanna Janicki, Max Augustin, Philipp Schommers, Leif Erik Sander et al. · 2022 · Cell Host & Microbe
  95. Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions
    Ge Liu, Brandon Carter, Trenton Bricken, Siddhartha Jain, Mathias Viard, Mary N Carrington, David Kenneth Gifford · 2020 · Cell Systems
  96. Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
    Sten Ilmjärv, Fabien Abdul, Silvia Acosta‐Gutiérrez, Carolina Estarellas, Ioannis Galdadas, Marina Casimir, Marco Alessandrini, Francesco Luigi Gervasio, Karl‐Heinz Krause · 2021 · Scientific Reports
  97. A single mutation in dairy cow-associated H5N1 viruses increases receptor binding breadth
    Marina R. Good, Monica L. Fernández‐Quintero, Wei Ji, Alesandra J. Rodriguez, Julianna Han, Andrew B. Ward, Jenna J. Guthmiller · 2024 · Nature Communications
  98. Variant analysis of 1,040 SARS-CoV-2 genomes
    Eric Christian Rouchka, Julia H. Chariker, Donghoon Chung · 2020 · PLoS ONE
  99. Plasticity in structure and assembly of SARS-CoV-2 nucleocapsid protein
    2022
  100. To Knot or Not to Knot: Multiple Conformations of the SARS-CoV-2 Frameshifting RNA Element
    Tamar Schlick A, Qiyao Zhu, Abhishek Dey, Swati Jain, Shuting Yan, Alain Laederach · 2021 · Journal of the American Chemical Society